A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Bladder Cancer
Trial Locations (6)

14627

RECRUITING

University of Rochester Medical Center, Rochester

75390

RECRUITING

UT Southwestern Medical Center at Dallas, Dallas

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

90095

RECRUITING

University of California Los Angeles, Los Angeles

Unknown

RECRUITING

Department of Urology, Nara Medical University, Nara

RECRUITING

Nara Precfecture Seiwa Medical Center, Nara

All Listed Sponsors
collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

University of Texas

OTHER

collaborator

Nara Medical University

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Nonagen Bioscience Corporation

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Rochester

OTHER

collaborator

Nara Prefecture Seiwa Medical Center

UNKNOWN

lead

Cedars-Sinai Medical Center

OTHER